Calcium folinate pentahydrate
Periampullary Adenocarcinoma
National Cancer Institute (NCI)Small moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Periampullary Adenocarcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Eloxatin National Cancer Institute (NCI) | Phase 2 | B |
CIS-DIAMMINEDICHLOROPLATINUM II New Mexico Cancer Research Alliance | Phase 2 | CCC |
Panobinostat New Mexico Cancer Research Alliance | Phase 2 | CCC |
FLUOROURACILUM National Cancer Institute (NCI) | Phase 2 | CCC |
S-1 Peking University | Phase 2 | CCC |
View all 10 →
Same molecule, other indications
Calcium folinate pentahydrate is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →